A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-12
DOI
10.1038/s41598-018-36394-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway
- (2018) Afsaneh Sadremomtaz et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Identification of Peptidic Antagonists of Vascular Endothelial Growth Factor Receptor 1 by Scanning the Binding Epitopes of Its Ligands
- (2017) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response
- (2016) Lucia De Rosa et al. Scientific Reports
- FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis
- (2015) Bin-Zhi Qian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Small Molecule Modulators of Protein–Protein Interactions: Selected Case Studies
- (2014) Madhu Aeluri et al. CHEMICAL REVIEWS
- Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists
- (2014) Lei Wang et al. MOLECULES
- Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells
- (2014) Tanja Mesti et al. PLoS One
- Signal Transduction by Vascular Endothelial Growth Factor Receptors
- (2013) S. Koch et al. Cold Spring Harbor Perspectives in Medicine
- Expression of VEGF Receptors on Endothelial Cells in Mouse Skeletal Muscle
- (2012) Princess I. Imoukhuede et al. PLoS One
- Characterization of a Designed Vascular Endothelial Growth Factor Receptor Antagonist Helical Peptide with Antiangiogenic Activity in Vivo
- (2011) Anna Basile et al. JOURNAL OF MEDICINAL CHEMISTRY
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
- (2010) Yohannes Mebratu et al. CELL CYCLE
- Structural Insights into the Binding of Vascular Endothelial Growth Factor-B by VEGFR-1D2
- (2010) Shalini Iyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biochemical and Structural Analysis of the Binding Determinants of a Vascular Endothelial Growth Factor Receptor Peptidic Antagonist
- (2010) Benoit Gautier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
- (2009) Christina L. Roland et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started